Literature DB >> 880076

Untreated ocular hypertension. A long-term prospective study.

Y Kitazawa, T Horie, S Aoki, M Suzuki, K Nishioka.   

Abstract

A prospective study was designed to determine the course of ocular hypertension without visual field loss if untreated and to estimate the value of various clinical findings in prediction the course of ocular hypertension. Seventy-five patients with intraocular pressure greater than 21 mm Hg but without demonstrable visual field defects were followed up without glaucoma therapy for a minimum of nine years. While under observation, seven of 75 ocular hypertensives developed typical glaucomatous visual field defects. Both the sensitivity and the specificity of each clinical finding in the individuals who later developed visual field defects were determined, and none of the clinical findings was found to be a good predictive indicator.

Entities:  

Mesh:

Year:  1977        PMID: 880076     DOI: 10.1001/archopht.1977.04450070078004

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  31 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Combined exfoliation and pigment dispersion: an overlap syndrome.

Authors:  R Mudumbai; J M Liebmann; R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  The pattern electroretinogram in glaucoma and ocular hypertension.

Authors:  E O'Donaghue; G B Arden; F O'Sullivan; F Falcão-Reis; B Moriarty; R A Hitchings; W Spilleers; C Hogg; G Weinstein
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

4.  [Not Available].

Authors:  R Hebert; J Y Dubois; C Fish; L Frenette; O Doiron; R Bernier
Journal:  Can Fam Physician       Date:  1981-03       Impact factor: 3.275

Review 5.  Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.

Authors:  Philip C Maier; Jens Funk; Guido Schwarzer; Gerd Antes; Yngve T Falck-Ytter
Journal:  BMJ       Date:  2005-07-01

6.  Epidemiological aids to clinical decision making in primary open angle glaucoma.

Authors:  R P Crick; J G Daubs
Journal:  Int Ophthalmol       Date:  1980-12       Impact factor: 2.031

7.  Results of the betaxolol versus placebo treatment trial in ocular hypertension.

Authors:  Deborah Kamal; David Garway-Heath; Simon Ruben; Fiona O'Sullivan; Catey Bunce; Anath Viswanathan; Wendy Franks; Roger Hitchings
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-19       Impact factor: 3.117

8.  Lateral differences indicate future glaucoma.

Authors:  A Thölen; L Tremmel; W Maurer; Y Robert; P Hendrickson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

9.  Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countries.

Authors:  Jean-Francois Rouland; Claude Le Pen; Carlos Gouveia Pinto; Patrizia Berto; Gilles Berdeaux
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Role of MYOC and OPTN sequence variations in Spanish patients with primary open-angle glaucoma.

Authors:  Francisco Lopez-Martinez; Maria-Pilar Lopez-Garrido; Francisco Sanchez-Sanchez; Ezequiel Campos-Mollo; Miguel Coca-Prados; Julio Escribano
Journal:  Mol Vis       Date:  2007-06-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.